Department of Pharmacy, University of Patras, Rion-Patras, 26500, Greece.
Clin Biochem. 2010 Feb;43(3):324-7. doi: 10.1016/j.clinbiochem.2009.09.014. Epub 2009 Sep 25.
Although numerous recent studies have focused on analyses of microRNA expression profiles in cancer cells, the expression patterns of the enzymes responsible for the generation of miRNAs remains largely unexplored. The purpose of this study was to investigate whether Dicer mRNA expression is altered during progression of ovarian cancer.
Total RNA was extracted from ovarian tissue specimens (normal, benign and malignant tumors). The expression of Dicer was analyzed by semi-quantitative RT-PCR.
We analyzed a total of 34 ovarian tissue samples and found that Dicer mRNA expression is down-regulated in the majority of ovarian tumors when compared to normal tissues.
Our results suggest that the levels of Dicer mRNA should be evaluated as a potential new candidate biomarker for ovarian cancer.
尽管最近有许多研究集中于分析癌细胞中 microRNA 表达谱,但负责生成 miRNAs 的酶的表达模式在很大程度上仍未得到探索。本研究旨在探讨 Dicer mRNA 表达在卵巢癌进展过程中是否发生改变。
从卵巢组织标本(正常、良性和恶性肿瘤)中提取总 RNA。通过半定量 RT-PCR 分析 Dicer 的表达。
我们共分析了 34 个卵巢组织样本,发现与正常组织相比,Dicer mRNA 在大多数卵巢肿瘤中表达下调。
我们的结果表明,Dicer mRNA 的水平可作为卵巢癌潜在的新型候选生物标志物进行评估。